83 FR 64159 - Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 239 (December 13, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 239 (December 13, 2018)
| Page Range | 64159-64159 | |
| FR Document | 2018-27039 |
[Federal Register Volume 83, Number 239 (Thursday, December 13, 2018)] [Notices] [Page 64159] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-27039] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 11, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on July 16, 2018, Cambrex High Point Inc., 4180 Mendenhall Oaks Parkway, High Point, North Carolina 27265 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Drug Controlled substances code Schedule ------------------------------------------------------------------------ Oxymorphone............................ 9652 II Noroxymorphone......................... 9668 II ------------------------------------------------------------------------ The company plans to manufacture the above listed controlled substances in bulk for distribution to its customers. Dated: December 3, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-27039 Filed 12-12-18; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 83, No. 239 / Thursday, December 13, 2018 / Notices 64159
Dated: December 3, 2018. Drug connection with suspension, denial, or
Controlled substance Schedule
John J. Martin, code revocation of registration) has been
Assistant Administrator. redelegated to the Assistant
Cocaine ......................... 9041 II Administrator of the DEA Diversion
[FR Doc. 2018–27036 Filed 12–12–18; 8:45 am]
Codeine ......................... 9050 II Control Division (‘‘Assistant
BILLING CODE 4410–09–P Dihydrocodeine .............. 9120 II
Oxycodone .................... 9143 II Administrator’’) pursuant to section 7 of
Hydromorphone ............. 9150 II 28 CFR part 0, appendix to subpart R.
DEPARTMENT OF JUSTICE Ecgonine ........................ 9180 II In accordance with 21 CFR
Hydrocodone ................. 9193 II 1301.33(a), this is notice that on July 16,
Drug Enforcement Administration Morphine ........................ 9300 II 2018, Cambrex High Point Inc., 4180
Thebaine ........................ 9333 II Mendenhall Oaks Parkway, High Point,
[Docket No. DEA–392]
North Carolina 27265 applied to be
The company plans to manufacture registered as a bulk manufacturer of the
Bulk Manufacturer of Controlled
the listed controlled substances for following basic classes of controlled
Substances Application: Eli-Elsohly
product development and reference substances:
Laboratories
standards. In reference to drug codes
ACTION: Notice of application. 7360 (marihuana) and 7370 (THC), the Controlled Drug Schedule
company plans to isolate these substances code
DATES: Registered bulk manufacturers of controlled substances from procured
7350 (marihuana extract). In reference to Oxymorphone ................ 9652 II
the affected basic classes, and Noroxymorphone ........... 9668 II
applicants therefore, may file written drug code 7360 (marihuana), no
comments on or objections to the cultivation activities are authorized for The company plans to manufacture
issuance of the proposed registration on this registration. No other activities for the above listed controlled substances in
or before February 11, 2019. these drug codes are authorized for this bulk for distribution to its customers.
ADDRESSES: Written comments should registration.
Dated: December 3, 2018.
be sent to: Drug Enforcement Dated: December 3, 2018.
John J. Martin,
Administration, Attention: DEA Federal John J. Martin,
Assistant Administrator.
Register Representative/DPW, 8701 Assistant Administrator.
Morrissette Drive, Springfield, Virginia [FR Doc. 2018–27039 Filed 12–12–18; 8:45 am]
[FR Doc. 2018–27029 Filed 12–12–18; 8:45 am]
22152. BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his DEPARTMENT OF JUSTICE
authority under the Controlled DEPARTMENT OF JUSTICE
Substances Act to the Administrator of Drug Enforcement Administration
the Drug Enforcement Administration Drug Enforcement Administration
[Docket No. DEA–392]
(DEA), 28 CFR 0.100(b). Authority to [Docket No. DEA–392]
exercise all necessary functions with Importer of Controlled Substances
respect to the promulgation and Bulk Manufacturer of Controlled Application: Noramco Inc.
implementation of 21 CFR part 1301, Substances Application: Cambrex
incident to the registration of High Point, Inc. ACTION: Notice of application.
manufacturers, distributors, dispensers,
importers, and exporters of controlled ACTION: Notice of application. DATES: Registered bulk manufacturers of
substances (other than final orders in the affected basic classes, and
DATES: Registered bulk manufacturers of applicants therefore, may file written
connection with suspension, denial, or the affected basic classes, and
revocation of registration) has been comments on or objections to the
applicants therefore, may file written issuance of the proposed registration on
redelegated to the Assistant comments on or objections to the
Administrator of the DEA Diversion or before January 14, 2019. Such
issuance of the proposed registration on persons may also file a written request
Control Division (‘‘Assistant or before February 11, 2019.
Administrator’’) pursuant to section 7 of for a hearing on the application on or
ADDRESSES: Written comments should before January 14, 2019.
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR be sent to: Drug Enforcement ADDRESSES: Written comments should
1301.33(a), this is notice that on Administration, Attention: DEA Federal be sent to: Drug Enforcement
November 22, 2017, Eli-Elsohly Register Representative/DPW, 8701 Administration, Attention: DEA Federal
Laboratories, Mahmoud A. Elsohly Morrissette Drive, Springfield, Virginia Register Representative/DPW, 8701
Ph.D., 5 Industrial Park Drive, Oxford, 22152. Morrissette Drive, Springfield, Virginia
Mississippi 38655 applied to be SUPPLEMENTARY INFORMATION: The 22152. All requests for hearing must be
registered as a bulk manufacturer of the Attorney General has delegated his sent to: Drug Enforcement
following basic classes of controlled authority under the Controlled Administration, Attn: Administrator,
substances: Substances Act to the Administrator of 8701 Morrissette Drive, Springfield,
the Drug Enforcement Administration Virginia 22152. All requests for hearing
Drug (DEA), 28 CFR 0.100(b). Authority to should also be sent to: (1) Drug
amozie on DSK3GDR082PROD with NOTICES1
Controlled substance Schedule
code exercise all necessary functions with Enforcement Administration, Attn:
respect to the promulgation and Hearing Clerk/OALJ, 8701 Morrissette
Marihuana Extract ......... 7350 I
Marihuana ...................... 7360 I
implementation of 21 CFR part 1301, Drive, Springfield, Virginia 22152; and
Tetrahydrocannabinols .. 7370 I incident to the registration of (2) Drug Enforcement Administration,
Dihydromorphine ........... 9145 I manufacturers, distributors, dispensers, Attn: DEA Federal Register
Amphetamine ................ 1100 II importers, and exporters of controlled Representative/DPW, 8701 Morrissette
Methamphetamine ......... 1105 II substances (other than final orders in Drive, Springfield, Virginia 22152.
VerDate Sep<11>2014 17:12 Dec 12, 2018 Jkt 247001 PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1](https://thefederalregister.org/doc/83_FR_64398/page/1.svg)
Document Created: 2018-12-13 01:16:07
Document Modified: 2018-12-13 01:16:07
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 11, 2019. | |
| FR Citation | 83 FR 64159 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR